XML 27 R20.htm IDEA: XBRL DOCUMENT
v3.25.4

Share Based Compensation | 6 Months Ended
--- | ---
Dec. 31, 2025
Share Based Compensation [Abstract] |
Share Based Compensation | Note 10. Share Based Compensation In December 2024, Neuphoria adopted its 2024 Equity Incentive Plan (“2024 Plan”). The maximum number of shares of common stock of the Company that are available for issuance under the 2024 Plan is 1,000,000 shares. The structure of equity awards is under the active review of the Compensation Committee to ensure it meets good corporate practice for a company of our size, nature, and company lifecycle. The Committee may, from time to time, grant options, stock appreciation rights, restricted stock, restricted stock units, stock bonus awards and/or performance awards to one or more eligible persons. At December 31, 2025, there were 863,230 shares available for grant under the 2024 Plan. The following table summarizes employee and non-employee share option activity for the six months ended December 31, 2025:
|  | Number of Options |  |  | Weighted Average Exercise Price per Share |  |  | Weighted Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value (1) |
|  |  |  |  |  |  |  | (in years) |  |  |  |
Outstanding as of June 30, 2025 |  |  | 91,211 |  |  | $ | 88.79 |  |  |  | 6.15 |  |  | $ | - |
Granted |  |  | 51,839 |  |  | $ | 8.27 |  |  |  | 9.91 |  |  | $ | - |
Lapsed |  |  | (6,023 | ) |  | $ | 18.85 |  |  |  | - |  |  | $ | - |
Outstanding as of September 30, 2025 |  |  | 137,027 |  |  | $ | 61.41 |  |  |  | 7.67 |  |  | $ | - |
Lapsed |  |  | (257 | ) |  | $ | 347.27 |  |  |  | - |  |  | $ | - |
Outstanding as of December 31, 2025 |  |  | 136,770 |  |  | $ | 61.41 |  |  |  | 7.67 |  |  | $ | - |
Options exercisable as of December 31, 2025 |  |  | 72,210 |  |  | $ | 106.68 |  |  |  | 5.72 |  |  | $ | - |
(1) The aggregate intrinsic value in the above table was calculated on the positive difference, if any, between the closing price per share of the Company’s common stock on December 31, 2025 of $3.88 and the per share exercise price of the underlying options. As of December 31, 2025, there was approximately $0.4 million of unrecognized compensation cost related to unvested employee share option awards outstanding, which is expected to be recognized as expense over a weighted average period o f 1.46 years. In determining the fair value of the share-based awards, the Company uses the Black-Scholes option-pricing model and assumptions discussed below. Each of these inputs is subjective and generally requires significant judgment to determine. The weighted average grant date fair value of options granted during the six months ended December 31, 2025 and 2024 was approximately $7.88 and $4.58 per share, respectively. During the three months ended December 31, 2025 and 2024, the Company recognized total share-based compensation expense of $0.1 million and less than $0.1 million, respectively. During the six months ended December 31, 2025 and 2024, the Company recognized total share-based compensation expense of $0.2 million and less than $0.1 million, respectively. Substantially all the share-based compensation expense was recorded as general and administrative expense in each period. Restricted Stock Units ("RSUs") Terms of RSU agreements, including vesting requirements, are determined by the board of directors or its compensation committee, subject to the provisions of the 2024 Plan. RSUs granted by the Company vest according to the terms of the underlying grant agreement and are awarded at the closing stock share price on the date of grant. In the event the recipient's employment with the Company terminates, any unvested underlying shares are forfeited and revert to the 2024 Plan. RSUs are not included in issued and outstanding common stock until vested and the underlying shares are released. There were 33,915 RSUs fully vested and unexercised at December 31, 2025. The Company recognized approximately $0.1 million of stock-based compensation expense associated with the RSUs for the six months ended December 31, 2025. As of December 31, 2025, the unexercised RSUs had an aggregate intrinsic value of $0.1 million.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration